Feature | July 17, 2012| Dave Fornell

Something Old is New Again in Cardiac Technology

Some ideas are ahead of their time, but become novel ideas for tomorrow

An image of an early 1980s hybrid OR installation at St. Joseph's Hospital in Atlanta, which never took off because it was an idea before its time.

Each year, I find it interesting that some “new” technology being introduced by a vendor is actually an old, recycled idea.  

A Siemens information technology executive showed me a video from the late 1970s of him as a young man demonstrating a futuristic computer system. It stored radiology images and reports electronically to eliminate the need for paper medical records. It was an idea 20 years ahead of its time, when the concept of a picture archiving and communications system (PACS) was very foreign. 

A reader recently commented on my online report from Heart Rhythm Society 2012. While working for Medtronic in the late 1990s, he came up with the idea of inexpensive, disposable, stick-on Holter monitors to make them easier to use.  The product concept was rejected at the time. He found it interesting I called two such monitors now on the market “most innovative new technology” 10 years later.

Arnoldo Fiedotin, M.D., who retired from practice 18 years ago, wrote me after reading DAIC’s coverage of the current trend toward hybrid operating rooms (ORs). He was a pioneer in interventional techniques and served 24 years as director of cardiac services at Atlanta’s St. Joseph’s Hospital. 

“Being retired, I generally do not keep up with advances. Reading your issue on hybrid ORs, however, prompted me to write you about my own experience. Back in the early 1980s at St. Joseph’s Hospital, and with the collaboration of Philips, I designed and they built a custom-made biplane cath lab that could double as an OR.  The table, of my own design, was not only detachable, but could rise and lower, tilt left and right, and do Trendelenburg and reverse Trendelenburg. A significant advantage was that once the patient had been centered on the beam of both imaging systems, one could go from right to left obliques by simply pressing a different foot pedal. It could also do cranio-caudal views. Due to the expense of the system and a very limited commercial market, the design was not advertised. I built it for the future, which I saw combining cardiology and surgery, but I was ahead of the times and no surgical interventions were performed.

“One thing we did was to have the detached table taken to the helipad, so the patients could be moved from the helicopter stretcher directly onto the cath table. I hasten to add that the treatment modalities at that time did not include angioplasty. When angioplasty became available, that table was, again, a factor in getting occasional emergencies to the lab much faster.”

He included a marketing photo of the system (above). Although showing technology from 30 years ago, the photo looks amazingly similar to the marketing photos of modern hybrid OR installations that vendors send me. 

Related Content

NCDR, ACC, JACC, American College of Cardiology, national trends, heart disease treatments, trends in cardiovascular care
News | Cath Lab| January 23, 2017
January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended thr
Lumedx, CVIS, Baylor Scott & White Health, BHVH, Texas
News | Cardiac PACS| January 17, 2017
Lumedx Corp. recently announced that it has implemented Phase 1 of a long-term, multiphase cardiovascular information...
Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable| January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
congenital heart patients, cardiac cath lab, anesthesia sedation practices, joint document, SCAI, SPA, CCAS
News | Congenital Heart| November 03, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA) and the...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
News | Drug-Eluting Balloons| November 03, 2016
The Spectranetics Corp. announced that it has submitted to the U.S. Food & Drug Administration (FDA) its Pre-Market...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting| November 02, 2016
Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers...
Overlay Init